Aqua Bio Technology - Share Issue/Capital Change 2026

Aqua Bio Technology ASA: Share capital increase registered

Reference is made to the stock exchange announcement by Aqua Bio Technology

ASA ("ABTEC" or the "Company") on 12 February 2026 regarding the agreement

with the sellers of Jetcarrier AS to convert NOK 50,000,000 of the currently

outstanding seller credit into new shares in the Company at the same

subscription price as in the private placement that was carried out by the

Company 12 February 2026 (the "Conversion"). Reference is further made to the

stock exchange announcement by the Company on 13 March 2026 regarding the

completion of the extraordinary general meeting in the Company. The general

meeting inter alia resolved to increase the Company's share capital by NOK

50,000,000 through the issuance of 10,000,000 new shares in connection with

the Conversion, each with a par value of NOK 5.00.

The share capital increase pertaining to the Conversion has now been

registered with the Norwegian Register of Business Enterprises. The new share

capital of ABTEC is NOK 76,139,675 divided by 15,227,935 shares, each with a

par value of NOK 5.00.

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR. The information was submitted for publication, through the

agency of the contact persons set out above, at 2026-03-23 12:02 CET.

AI assistant